Biostar Pharmaceuticals, Inc. (BSPM) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Biostar Pharmaceuticals, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-1.17
Cash-Rich Deficit
P/B Ratio
0.18
Strong
WeakModerateStrong
Earnings Yield
-84.66%
Yield Gap
Profitability Health
2016Return on Equity
-15.45%
Weak
WeakModerateStrong
Operating Margin
-149.50%
Weak
WeakModerateStrong
Net Profit Margin
-239.01%
Weak
WeakModerateStrong
Growth Indicators
2016Revenue Growth
-91.21%
Weak
WeakModerateStrong
Net Income Growth
77.31%
Strong
WeakModerateStrong
EPS Growth
77.99%
Strong
WeakModerateStrong
Efficiency & Liquidity
2016Current Ratio
1.31
Moderate
WeakModerateStrong
Quick Ratio
1.28
Moderate
WeakModerateStrong
Asset Turnover
0.06x
Weak
WeakModerateStrong
Inventory Turnover
8.82x
Strong
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
72.99%
Strong
WeakModerateStrong
EV / Free Cash Flow
1.81x
Strong
WeakModerateStrong
Net Debt / EBITDA
-1.27x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.854
Moderate
WeakModerateStrong
Return on Invested Capital
-9.09%
Weak
WeakModerateStrong
Cash Conversion Cycle
384.61 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for BSPM.
View Financial Statements